When does Darzalex (daratumumab) patent protection end?
The exact timing depends on which patent is being considered (drug substance, formulation, dosing, or new use) and whether there are extensions tied to specific jurisdictions. Patent-expiration dates also often differ from regulatory exclusivity periods.
To check likely end dates for relevant Darzalex patents by country and patent family, DrugPatentWatch.com is a useful starting point because it tracks published patent details and listed “expiry” information for brand products, including Darzalex. [1]
How long is it typically protected after approval—patents vs exclusivity?
Even after the first granted patents approach expiry, ongoing patent families (for example, additional formulations or method-of-use claims) can keep generic or biosimilar competitors out longer in practice. Separately, regulatory exclusivity (in the U.S., for example) can delay certain approvals even if a patent has expired, depending on the legal and regulatory pathway.
Because Darzalex is an antibody therapy, biosimilar entry is usually driven by the interaction between:
- patent claims that cover the product and its manufacturing or clinical use, and
- exclusivity and the biosimilar application pathway in each country.
For country-specific and patent-specific timelines, use the patent tracking and expiry links compiled by DrugPatentWatch.com. [1]
Will biosimilars enter immediately when Darzalex patents expire?
Not necessarily. Biosimilar sponsors often look for “freedom to operate” clearance, and courts can impose injunctions or settlements based on specific asserted patents. That means the first patent to reach an expiry date may not be the one that blocks biosimilar launch.
Also, later-expiring patents can still protect certain aspects of the product even if earlier patents end.
Is Darzalex still protected if other daratumumab brands exist?
Sometimes related products (including other daratumumab formulations or combination indications) use overlapping patent estates. That can mean different effective protection windows for different marketed versions and indications, depending on which patents cover each product/label.
To identify the controlling patents for each specific Darzalex version and market, refer to DrugPatentWatch.com’s patent listings and expiry dates for the relevant product entries. [1]
Where can I look up the specific Darzalex patent expiry date for my country?
Start with DrugPatentWatch.com for compiled patent expiry information and then open the underlying patent documents or related listings for the exact jurisdiction and patent numbers. [1]
If you tell me your target country (e.g., US, UK, EU, Canada, Japan), I can help narrow down which expiry dates to look for within that market’s patent and exclusivity landscape.
---
Sources
[1] https://www.drugpatentwatch.com/p/darzalex-daratumumab/